A study from the University of Arizona shows that the protein PNA5 helps protect brain cells, offering a promising avenue for treating cognitive symptoms in Parkinson’s disease, a condition currently ...
Kite, a Gilead Company (Nasdaq: GILD), today announced findings from three new analyses for Yescarta® (axicabtagene ciloleucel) that demonstrate improved outcomes for people living with relapsed or ...
The theory that BHB supplementation could improve response to CAR T cell therapy is being tested in a Phase I clinical ... CAR T cell therapy is a personalized treatment approach, pioneered at Penn ...